Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients.

Barnabe BouvarelOliver ColombanJean-Sebastien FrenelCécile LoaecCharlotte BourginDominique BertonGilles FreyerBenoit YouJean-Marc Classe

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)

Primary tumor chemosensitivity, assessed by the modeled CA-125 KELIM, calculated during neoadjuvant chemotherapy, is a major parameter to consider for decision making regarding interval surgery. Complementary to the RECIST score and laparoscopy, this non-invasive tool, available online, helps tailor the interval surgery strategy according to patient tumor chemosensitivity.

Keyphrases

neoadjuvant chemotherapy
minimally invasive
coronary artery bypass
decision making
locally advanced
lymph node
sentinel lymph node
high grade
surgical site infection
robot assisted
healthcare
protein kinase
health information
acute coronary syndrome